Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04339062
Title Cemiplimab in AlloSCT/SOT Recipients With CSCC (CONTRAC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

skin squamous cell carcinoma

Therapies

Cemiplimab

Cemiplimab + Everolimus + Prednisone

Cemiplimab + Prednisone + Sirolimus

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.